Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12576282 | 0.91 | NOS1 (0.31) | NOS1NOS2 | |
| SCHEMBL12640519 | 0.90 | AR (0.34) | ESR1ESR2 | |
| SCHEMBL12640520 | 0.89 | GABRG2 (0.38) | GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL12640478 | 0.87 | GABRG2 (0.32) | GABRG2GABRB3GABRA5GABRA3PGR | |
| SCHEMBL12640532 | 0.86 | MAPK14 (0.32) | PGR | |
| SCHEMBL12640508 | 0.86 | GABRG2 (0.36) | GABRG2GABRB3GABRA5GABRA3PGR | |
| SCHEMBL12640517 | 0.85 | GABRG2 (0.40) | GABRG2GABRB3GABRA5GABRA3PGR | |
| SCHEMBL179187 | 0.85 | ENPP2 (0.38) | PGR | |
| SCHEMBL12640421 | 0.85 | ALDH1A1 (0.36) | GABRG2GABRB3GABRA5GABRA3PGR | |
| SCHEMBL12640488 | 0.85 | PGR (0.34) | PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9126892-B2 | Blue fluorescence compound and organic electroluminescence device using the same | LG DISPLAY CO., LTD. (KR) | 2015-09-08 | — | — | US | disclosed |
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | KCNN2, ORAI2, ETV6 | NOS1 1348/4885NOS2 854/4885SYK 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.